- /
- Supported exchanges
- / US
- / CYPH.NASDAQ
Cypherpunk Technologies Inc. (CYPH NASDAQ) stock market data APIs
Cypherpunk Technologies Inc. Financial Data Overview
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Cypherpunk Technologies Inc. data using free add-ons & libraries
Get Cypherpunk Technologies Inc. Fundamental Data
Cypherpunk Technologies Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cypherpunk Technologies Inc. News
New
Winklevoss Twins Donate $1.2M to Zcash’s Shielded Labs Amid ECC Exodus
Tyler and Cameron Winklevoss donated 3,221 ZEC (approximately $1.2 million) to Shielded Labs on Tuesday, the Swiss-based nonprofit confirmed, marking their second contribution to the independent Zcash...
Crypto Long & Short: 2026: The year institutions treat crypto as part of their core stack
Happy New Year! Welcome to our institutional newsletter, Crypto Long & Short. This week: Adeniyi Abiodun predicts that 2026 is the year Wall Street starts building on blockchain, not around it. Andy ...
Winklevoss-backed Cypherpunk buys $28 million of zcash, now owns 1.7% of supply
Cypherpunk Technologies (CYPH), a digital asset treasury firm backed by the Winklevoss twins, said it bought $28 million worth of privacy coin zcash (ZEC), taking its overall holdings to 290,062 ZEC (...
Is Zcash the Next Corporate Treasury Play? Cypherpunk Now Holds Nearly 2%
Cypherpunk Technologies has deepened its bet on Zcash, adding fuel to a growing debate over whether privacy-focused cryptocurrencies can play a role similar to Bitcoin in corporate treasuries. The Na...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.